Drug Discovery & Development (Online)
Drug Discovery & Development
This concentration is a fully Hybrid-Online version of the traditional Master of Business & Science (MBS) degree with a concentration in Drug Discovery & Development. Classes will be held online. Students are expected to complete the program in about 2 years (see schedule below). See below for information and application instructions.)
The objective of the Master of Business & Science with a concentration in Drug Discovery and Development is to provide broad-based training for students in the areas of Drug Discovery, Drug Development, Regulatory Affairs, and Clinical Trials Management. Students will learn about the pharmaceutical development process and acquire analytical and communication skills suitable for managerial and staff positions in laboratory and clinical research, clinical trials, contract research organizations, federal regulatory agencies – such as the FDA - and pharmaceutical marketing.
Students must have an undergraduate background in the biological sciences, chemistry, engineering, or a health-related field, or have work experience in one of those fields. Prerequisite coursework must include the following: two semesters of biology; two semesters of chemistry; two semesters of organic chemistry; and one semester of either Molecular Biology or Biochemistry. Students who have taken courses in physiology, genetics or cell biology are preferred.The General GRE is required for admission.
For the Master of Business & Science (MBS) degree, students take 24 credits in the sciences and 19 credits in business.
The On-Site Residency is mandatory for all online students, including out-of-state students. Click here for more information.
I. Business Courses
A total of 19 credits are required in the business curriculum. Six courses are required - all but one of the courses are for 3 credits each. Descriptions of the required Business Courses can be found here:
- Principles of Communication and Professional Development (16:137:502) (3cr)
- Principles of Accounting and Finance for Science and Technology (16:137:530) (3cr)
- Market Assessment and Analysis for Business and Science - Life Sciences (16:137:507) (3cr)
- Ethics in Science and Technology Management (16:137:500) (1cr)
- Science and Technology Management Capstone (16:137:600) (3cr)
- and 2 business elective (e.g., Project Management, Biopharma Management, et al) (3cr)
II. Science Courses
A total of 24 credits are required in the science curriculum. Five courses are required, all of which are for 3 credits each. Descriptions of the required Science Courses can be found here:
- Drug Development: From Concept to Market (16:137:510) (3cr)
- Drug Discovery Through Preclinical Development (16:137:511) (3cr)
- Practical Aspects of Clinical Trial Design (16:137:580) (3cr)
- Statistics in Clinical and Translational Research (16:137:581) (3cr)
- Fundamentals of Regulatory Affairs (16:137:582) (3cr)
- Fundamentals of Intellectual Property (16:137:501) (3cr)
- Fundamentals of Biological Chemistry in the Biotech Industry (16:137:512) (3cr)
- and 1 science elective (3cr)
The program starts in the Spring or Fall semester and completes in about 2-3 years according to the following schedule:
Drug Discovery & Development: Example of Online Course Plan (Fall start)
Drug Discovery & Development: Example of Online Course Plan (Spring start)
Python Methodologies for Data Science (16:137:552)
Fundamentals of Analytics (16:137:550)
Data Analytics for Business Professionals (17:610:561)
Please note: Students will be required to spend one week on-site at Rutgers University. The purpose of this week is to provide students an opportunity to make presentations required in their respective courses. Accommodations during this on campus meeting are covered for students in the program (not travel).